Although HER3 is also activated through transcriptionally increased neuregulin in BRAFV600E melanoma cell lines following exposure to BRAFi and/or MEKi, HER3 activation mainly leads to protein kinase B (AKT) hyperphosphorylation. The gene discussed is AKT1; the disease is melanoma.